PNT-2258

N/A

Report date: 2025/04/23 20:01:04
NME

Base Information

Drug NamePNT-2258
Drug Alias NameRosomidnar liposomalPNT-2258
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsRichter's SyndromeProstatic NeoplasmsMelanoma +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPronai
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSierra Oncology LLC
Active IndicationsN/A
Inactive IndicationsRichter's SyndromeProstatic NeoplasmsMelanoma +[7

Other Information

ATC CodeN/A
Related LinksN/A